πŸ‡ΊπŸ‡Έ FDA
Patent

US 9783578

Immunosuppression modulating compounds

granted A61KA61K38/00

Quick answer

US patent 9783578 (Immunosuppression modulating compounds) held by Aurigene Discovery Technologies Limited expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00